Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Pharmaceutical Import Guides by Region: Registration, Tenders and Special Import (2026)

Mitul Agarwal
Written by Mitul Agarwal · B.Pharm, MBA
Founder & Head of Business Development · 25+ years in international pharmaceutical BD&L
Published 28 September 2026
Pharmaceutical Import Guides by Region: Registration, Tenders and Special Import (2026)

Last updated: 28 September 2026. New guides get added here as they go live.

"Can I sell my product in this country?" It's the question every exporter asks sooner or later. And the honest answer is: it depends. Who's allowed to import? How long does registration take? Who buys, pharmacies, hospitals or the government? Does the country want it made locally instead? So I've put it all down, one region at a time, in plain words.

Every guide covers every country, not just the big names. Start with the region you care about.

In a hurry?

  • Buying or bidding on a tender? Post an RFQ and we'll find you GMP-certified manufacturers for your market.
  • Need an unregistered medicine for a patient? Send us an RFP.
  • A manufacturer? List your products so buyers can find you.

The guides

Latin America and the Caribbean
Brazil and Mexico get the most attention, but don't skip the smaller markets. Some good openings are in smaller places like Guatemala, Paraguay or the Caribbean islands.

Middle East and North Africa
Get registered with the Gulf Health Council and six Gulf markets open up at once. Egypt, Algeria and Iraq each have their own twists, and getting paid is half the job.

Sub-Saharan Africa
Lots of regulators, but also real shortcuts: one dossier can now be reviewed for several countries together. Check the local-manufacturing lists before you file.

Russia and the CIS
The EAEU is moving to one set of rules, Uzbekistan is opening up fast, and Ukraine is going EU-style. Plan how you'll get paid before you quote.

South Asia (SAARC)
India makes most of its own generics, but still imports new medicines, biologicals and APIs. Bangladesh's patent waiver is ending, and the Maldives can approve in 20 days.

Southeast Asia (ASEAN)
Same dossier format everywhere, very different rules. Singapore and Malaysia move fast if you have FDA or EMA approval. Indonesia only lets local manufacturers register.

What's next

The US, Europe, the UK, Australia, Japan, Korea, China and Turkey. These are a different game: less about who imports, more about how you get approved in the first place.

New to exporting? Start here

Can't find your answer?

Rules change and no guide covers every product. Just tell us the product and the country, and we'll point you to a manufacturer or a local partner who can help. Post an RFQ, or send an RFP for a patient.

Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.

Category: Pharma Blogs

← Back to All Articles

 

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.